RxDoctor Payments Data

Michelle Asteak, PA

Medical · Allentown, PANPI 1134648967

Payments from drug & device makers

$5,195in general payments, 2019–2025

Across 69 payments — averaging $75.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Gilead$681
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$505
  • E.r. Squibb & Sons, L.L.C.$427
  • Regeneron Healthcare Solutions, Inc.$296
  • Janssen Scientific Affairs, LLC$250
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$5,195100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,195 in reported general payments places this provider in the 90th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$22,099
Medicare patients
225
Services billed
262

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide70$40,313
Mesalamine DrMesalamine11$5,424
Sucralfate14$4,581
Pantoprazole Sodium250$3,506
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C24$3,383
Omeprazole233$2,526
CholestyramineCholestyramine (With Sugar)40$2,327
Esomeprazole Magnesium31$1,823
Lubiprostone13$1,548
Famotidine110$1,526
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl57$908
Dicyclomine Hcl59$837
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine32$508
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl21$321
Spironolactone11$157

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,723$40,31370 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu$505$3,38324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Allentown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →